Nicholas N. Vahanian

2019

In 2019, Nicholas N. Vahanian earned a total compensation of $1.2M as Former President at NewLink Genetics, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$133,877
Option Awards$239,648
Salary$406,778
Other$439,000
Total$1,219,303

Vahanian received $439K in other compensation, accounting for 36% of the total pay in 2019.

Vahanian also received $133.9K in non-equity incentive plan, $239.6K in option awards and $406.8K in salary.

Rankings

In 2019, Nicholas N. Vahanian's compensation ranked 8,351st out of 13,971 executives tracked by ExecPay. In other words, Vahanian earned more than 40.2% of executives.

ClassificationRankingPercentile
All
8,351
out of 13,971
40th
Division
Manufacturing
3,300
out of 5,701
42nd
Major group
Chemicals And Allied Products
1,251
out of 2,200
43rd
Industry group
Drugs
1,063
out of 1,886
44th
Industry
Pharmaceutical Preparations
789
out of 1,398
44th
Source: SEC filing on June 23, 2020.

Vahanian's colleagues

We found six more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2019.

2019

Charles Link

NewLink Genetics

Former Chief Executive & Scientific Officer

2019

Eugene Kennedy

NewLink Genetics

Chief Medical Officer

2019

Carl Langren

NewLink Genetics

Chief Financial Officer

2019

Richard Hawkins

NewLink Genetics

Chief Executive Officer

2019

Bradley Powers

NewLink Genetics

General Counsel

2019

John McKew

NewLink Genetics

Chief Operating Officer

News

You may also like